1. Home
  2. HALO vs FAF Comparison

HALO vs FAF Comparison

Compare HALO & FAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • FAF
  • Stock Information
  • Founded
  • HALO 1998
  • FAF 1889
  • Country
  • HALO United States
  • FAF United States
  • Employees
  • HALO N/A
  • FAF N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FAF Specialty Insurers
  • Sector
  • HALO Health Care
  • FAF Finance
  • Exchange
  • HALO Nasdaq
  • FAF Nasdaq
  • Market Cap
  • HALO 6.4B
  • FAF 6.7B
  • IPO Year
  • HALO N/A
  • FAF N/A
  • Fundamental
  • Price
  • HALO $50.51
  • FAF $60.76
  • Analyst Decision
  • HALO Buy
  • FAF Buy
  • Analyst Count
  • HALO 9
  • FAF 4
  • Target Price
  • HALO $61.11
  • FAF $74.50
  • AVG Volume (30 Days)
  • HALO 1.3M
  • FAF 496.6K
  • Earning Date
  • HALO 02-18-2025
  • FAF 02-12-2025
  • Dividend Yield
  • HALO N/A
  • FAF 3.49%
  • EPS Growth
  • HALO 61.71
  • FAF N/A
  • EPS
  • HALO 3.02
  • FAF 0.88
  • Revenue
  • HALO $947,355,000.00
  • FAF $5,872,300,000.00
  • Revenue This Year
  • HALO $23.36
  • FAF N/A
  • Revenue Next Year
  • HALO $15.35
  • FAF $19.75
  • P/E Ratio
  • HALO $16.69
  • FAF $70.40
  • Revenue Growth
  • HALO 21.35
  • FAF N/A
  • 52 Week Low
  • HALO $33.15
  • FAF $51.60
  • 52 Week High
  • HALO $65.53
  • FAF $70.92
  • Technical
  • Relative Strength Index (RSI)
  • HALO 59.63
  • FAF 31.39
  • Support Level
  • HALO $47.52
  • FAF $61.34
  • Resistance Level
  • HALO $49.00
  • FAF $63.03
  • Average True Range (ATR)
  • HALO 1.39
  • FAF 1.39
  • MACD
  • HALO 0.38
  • FAF -0.28
  • Stochastic Oscillator
  • HALO 93.30
  • FAF 4.93

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through two segments: title insurance and related services and Home warranty. Title insurance and related services include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services. The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period. Nearly all the company's revenue comes from the title insurance and related services segment in the United States.

Share on Social Networks: